Proton MR Spectroscopy to diagnose Multiple Sclerosis at early stages

With growing technology medicine has also grown to greater heights, with newer advancements in diagnosis and treatment. MR spectroscopy a new advancement in radiology compares the chemical composition of normal brain tissue.

The journal Radiology suggests that MR spectroscopic imaging at 7.0 T can identify changes in the brains of patients with multiple sclerosis (MS) that were not visible at T1- or T2-weighted MRI. Further, metabolic abnormalities in the normal-appearing white matter and cortical gray matter were found to be related to disability.

Previous studies have shown that MR spectroscopic imaging (MRSI) allows in vivo assessment of brain metabolism. Also, it is of special interest in MS, where morphologic MRI cannot depict major parts of disease activity. Wolfgang Bogner, and the team therefore, aimed to evaluate the ability of 7.0-T MRSI to depict and visualize pathologic alterations in the normal-appearing white matter (NAWM) and cortical gray matter (CGM) in patients with MS and to investigate their relation to disability.

For more information check out the full story on the link below:

7T proton MR spectroscopic imaging can identify brain changes in multiple sclerosis: Study